Sign in
Facet browsing currently unavailable
Page 10 of 2476 results
Sort by: relevance publication year
|
Inhibition of chikungunya virus replication by N-ω-Chloroacetyl-L-Ornithine in C6/36, Vero cells and human fibroblast BJ JOURNAL ARTICLE published February 2023 in Antiviral Therapy Research funded by Instituto Politécnico Nacional (SIP 20195289) |
|
Mitochondrial Function, Inflammation, Fat and Bone in HIV Lipoatrophy: Randomized Study of Uridine Supplementation or Switch to Tenofovir JOURNAL ARTICLE published February 2012 in Antiviral Therapy |
|
Antibodies for prevention and treatment of respiratory syncytial virus infections in children JOURNAL ARTICLE published 2012 in Antiviral Therapy |
|
Age and Total Ribavirin Dose are Independent Predictors of Relapse after Interferon Therapy in Chronic Hepatitis C Revealed by Data Mining Analysis JOURNAL ARTICLE published January 2012 in Antiviral Therapy |
|
Response to Anti-HCV Therapy in HIV–HCV-Coinfected Patients: Does the Lipid Profile Really have an Effect? JOURNAL ARTICLE published July 2010 in Antiviral Therapy |
|
Pegylated Interferon-α2b plus Ribavirin Therapy in Patients with Hepatitis C and Psychiatric Disorders: Results of a Cohort Study JOURNAL ARTICLE published May 2010 in Antiviral Therapy |
|
Selection and Characterization of HIV-1 Variants Resistant to the (+) and (-) Enantiomers of 2′-Deoxy-3′-Oxa-4′-Thiocytidine (Dotc) JOURNAL ARTICLE published April 1999 in Antiviral Therapy |
|
Immune Restoration in HIV-Positive, Antiretroviral-Naive Patients after 1 Year of Zidovudine/Lamivudine plus Nelfinavir or Nevirapine JOURNAL ARTICLE published February 2004 in Antiviral Therapy |
|
A Phase I, Randomized, Placebo-Controlled, 3-Day, Ascending-Dose Study of Gs-9451, An Ns3/4A Protease Inhibitor, in Genotype 1 Hepatitis C Patients JOURNAL ARTICLE published April 2013 in Antiviral Therapy |
|
Long-Term Virological Outcome in Patients Infected with Multi-Nucleoside Analogue-Resistant HIV-1 JOURNAL ARTICLE published May 2002 in Antiviral Therapy |
|
Antiviral Drug Resistance: From the Laboratory to the Patient JOURNAL ARTICLE published May 1998 in Antiviral Therapy |
|
Preclinical Characterization of the Novel HCV NS3 Protease Inhibitor GS-9256 JOURNAL ARTICLE published July 2017 in Antiviral Therapy |
|
Expert Opinion on Managing Chronic HCV in Patients with Neuropsychiatric Manifestations JOURNAL ARTICLE published January 2018 in Antiviral Therapy |
|
Haematological Changes in Adults Receiving a Zidovudine-Containing Haart Regimen in Combination with Cotrimoxazole in Côte D'ivoire JOURNAL ARTICLE published July 2005 in Antiviral Therapy |
|
Rhabdomyolysis in An HIV-Infected Patient with Impaired Renal Function Concomitantly Treated with Rosuvastatin and Lopinavir/Ritonavir JOURNAL ARTICLE published April 2011 in Antiviral Therapy |
|
Gene Polymorphism of Thymidine Kinase and Dna Polymerase in Clinical Strains of Herpes Simplex Virus JOURNAL ARTICLE published October 2011 in Antiviral Therapy |
|
A Non-Randomized Multicentre Trial of Human Immune Plasma for Treatment of Hantavirus Cardiopulmonary Syndrome Caused by Andes Virus JOURNAL ARTICLE published May 2015 in Antiviral Therapy |
|
Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression JOURNAL ARTICLE published February 2009 in Antiviral Therapy |
|
Prolonged exposure to tenofovir monotherapy 1 month after treatment discontinuation because of tenofovir-related renal failure JOURNAL ARTICLE published February 2009 in Antiviral Therapy |
|
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B JOURNAL ARTICLE published December 2022 in Antiviral Therapy |